Spots Global Cancer Trial Database for ONO-7436 Phase II Study in Japan
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ONO-7436 Phase II Study in Japan
Official Title: ONO-7436 Phase II Study - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of ONO-7436 for the Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting in Japan
Study ID: NCT00212602
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to examine the efficacy and safety of ONO-7436 for the prevention of cancer chemotherapy-induced nausea and vomiting in patients with malignant tumor
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chubu Region Facility, Chubu, , Japan
Chugoku Region Facility, Chugoku, , Japan
Hokkaido Region Facility, Hokkaido, , Japan
Hokuriku Region Facility, Hokuriku, , Japan
Kanto Region Facility, Kanto, , Japan
Kinki Region Facility, Kinki, , Japan
Kyushu Region Facility, Kyushu, , Japan
Shikoku Region Facility, Shikoku, , Japan
Tohoku Region Facility, Tohoku, , Japan
Contact Details
Name: Project Leader, Development Planning
Affiliation: Ono Pharmaceutical Co. Ltd
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
